Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF)
ImmunoHorizons · 18.02.2025 · 9 (4)
DOI: 10.1093/immhor/vlae013 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, online erschienen am 18.02.2025. Verfasst von Sangeeta Kowli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, United States. Hauptthemen laut MEDLINE: Kidney Transplantation, CD8-Positive T-Lymphocytes, Leukocytes, Mononuclear. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, Amgen Corporation.
Abstract (Originalsprache)
Chronic immunosuppressive therapies are crucial in organ transplantation but can increase the risk of opportunistic infections and cancer over time. We investigated immune status changes in 10 kidney transplant patients and 11 age-matched healthy adults using broad in vitro stimulation of subject-derived peripheral blood mononuclear cells followed by mass cytometry by time of flight over 6 mo. Overall, the immune cells of transplant patients exhibited increased CD8+ T cell activation and differentiation compared with healthy donors, with elevated CD8+ CD57+, MIP-1β, and interferon γ production (P < 0.05, P < 0.05, and P < 0.01, respectively). CD107a and granzyme B expression were increased in CD8+ T cells and CD56bright natural killer cells (P < 0.05 and P < 0.01, respectively), while T regulatory cells had decreased interleukin-10 production (P < 0.05). These changes indicated a proinflammatory environment influenced by induction therapy and ongoing maintenance drugs. Additionally, transplant recipients displayed signs of immune modulation, including decreased tumor necrosis factor α, interferon γ, and MIP-1β expression in γδT cells (P < 0.05 and P < 0.01), and reduced interleukin-17 and granulocyte-macrophage colony-stimulating factor expression in CD8+ T memory cell subsets (P < 0.05). The diverse functional changes underscore the importance of comprehensive immune status profiling for optimizing individual treatment strategies and developing better immunosuppressants that specifically target activated cell populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, United States.
- Department of Microbiology and Immunology, School of Medicine, Stanford University, Stanford, CA, United States.
- Amgen Inc., Thousand Oaks, CA, United States.
- Eli Lilly and Company, Indianapolis, IN 46285, United States.
- Division of Abdominal Transplantation, Department of Surgery, Stanford University, Stanford, CA, United States.
- Sonoma Biotherapeutics, South San Francisco, CA 94080, United States.
ORCID-Profile: Olivia M Martinez, Stephan Busque, Herve Lebrec, Holden T Maecker
Förderung
- NIAID NIH HHS
- NIH HHS
- Amgen Corporation
- National Institutes of Health
Zitieren
APA
Kowli, S., Minocherhomji, S., Martinez, O. M., Busque, S., Lebrec, H., & Maecker, H. T. (2025). Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF). ImmunoHorizons, 9(4). https://doi.org/10.1093/immhor/vlae013
Vancouver
Kowli S, Minocherhomji S, Martinez OM, Busque S, Lebrec H, Maecker HT. Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF). ImmunoHorizons. 2025;9(4). doi:10.1093/immhor/vlae013
BibTeX
@article{Kowli2025,
author = {Kowli, Sangeeta and Minocherhomji, Sheroy and Martinez, Olivia M and Busque, Stephan and Lebrec, Herve and Maecker, Holden T},
title = {Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF)},
journal = {ImmunoHorizons},
year = {2025},
volume = {9},
number = {4},
doi = {10.1093/immhor/vlae013}
}
EUVIMED